{"url_path":"/sec/ensc/8-k/2026-07-15/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 **","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-07-15","source_url":"https://www.sec.gov/Archives/edgar/data/1716947/0001493152-26-033360-index.html","accession_number":"0001493152-26-033360","cik":"0001716947","ticker":"ENSC","issuer_name":"Ensysce Biosciences, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1716947/0001493152-26-033360-index.html","primary_entity_key":"0001716947","primary_entity_name":"Ensysce Biosciences, Inc."},"word_count":77,"has_tables":true,"body_markdown":"**Item\n9.01**\n**Financial\nStatements and Exhibits.**\n\n \n\n(d)\n*Exhibits*.\n\n \n\nExhibit\nNo.\n \nDescription\n\n \n \n \n\n104\n \nCover\nPage Interactive Data File (embedded within the Inline XBRL document).\n\n \n\n2\n\n \n\n \n\n**SIGNATURES**\n\n \n\nPursuant\nto the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by\nthe undersigned hereunto duly authorized.\n\n \n\nDated:\nJuly 15, 2026\n\n \n\n \n**Ensysce\nBiosciences, Inc.**\n\n \n \n \n\n \nBy:\n*/s/\nLynn Kirkpatrick*\n\n \nName: \n\nDr.\nLynn Kirkpatrick\n\n \nTitle:\nPresident\nand Chief Executive Officer\n\n \n\n3"}